Johnson & Johnson VP of investor relations to retire
Ms. Mehrotra first joined the Johnson & Johnson Family of Companies in 1980, and has led Investor Relations for more than 10 years.
Joseph Wolk will replace Ms. Mehrotra as Vice President, Investor Relations, effective August 1, 2016.
Mr. Wolk was previously Vice President, Group Finance for the Pharmaceuticals Group of Johnson & Johnson.
Prior to that role, he held other finance leadership positions at Johnson & Johnson as Vice President of Finance for the Medical Devices Global Supply Chain, and as Chief Financial Officer of the North America Pharmaceuticals Group, responsible for Centocor Ortho Biotech Inc., as well as U.S. Pricing Strategy and Compliance.
Mr. Wolk joined Johnson & Johnson in 1998 as a Finance Manager in the Ortho-McNeil Pharmaceutical organization.
Prior to joining Johnson & Johnson, Mr. Wolk held multiple positions of increasing responsibility at Ametek, Inc.
He holds a Bachelor of Science degree in Finance from St. Joseph’s University, where he currently serves on the Haub School of Business Board of Visitors, and he also holds a Juris Doctor degree from Temple University School of Law and is a Certified Public Accountant. ■
LATEST MOVES FROM New Jersey
- Campbell Soup Company appoints Fabiola R. Arredondo to board
- Eagle Pharmaceuticals names Richard A. Edlin to board
- Tom Gebhardt chairman and CEO of Panasonic Corp. of North America
- Celgene Corporation COO Jacqualyn Fouse to retire
- Innophos appoints Kim Ann Mink as chairman of the board
More inside POST